Sun Yat-sun University Cancer Center, Guangzhou, P. R. China.
State Key Laboratory of Oncology in South China, Guangzhou, P. R. China.
Technol Cancer Res Treat. 2023 Jan-Dec;22:15330338231169601. doi: 10.1177/15330338231169601.
To analyze the relationship between the rotational and residual setup errors and the dose deviation on nasopharyngeal carcinoma (NPC) treated by helical tomotherapy (HT).
From 25 July 2017 to 20 August 2019, 16 treated NPC patients were enrolled in the study. These patients were scanned with full target range megavoltage computed tomography (MVCT) every other day. Adaptive radiotherapy function application software MIM7.1.3 were used to accumulate the actual dose. The dose deviation with the initial plan dose of the patients' target and organs at risk (OAR) were compared, and the correlation between the dose change and the setup errors (rotational setup errors and neck residual setup error) was analyzed.
Translational setup errors increased farther away from the head. Statistically significant difference among 3 groups was achieved in the directions of left-right ( < .001) and anteroposterior ( < .001) by analysis of variance test. Compared with the initial plan dose, the actual accumulated dose of the target area decreased with the actual exposure dose of the OAR increased. However, most of the dosimetric parameters differed by less than 5%. No correlation was found between dose deviation values and the translational setup errors of target. However, sagittal rotational setup errors (pitch) had a positive relationship ( < .05) with the avearge dose of PTVnd (L) ( = 0.885), PTVnd(R) ( = 0.547) PTV1( = 0.633) and PTV2( = 0.584). Transverse rotational setup errors (roll) had a positive relationship ( < .05) with the avearge dose of PTVnd(R) ( = 0.593), PTV1( = 0.505) and PTV2( = 0.662).
Dose deviation between the actual accumulated and initial plan is not negligible, but most indicators difference is less than 5%, NPC patients treated by HT with MVCT correction setup errors every other day did not need adaptive radiotherapy model unless got rapid tumor shrinkage or weight loss. Moreover, to minimize the dose deviation, more attention should be paid to the reduction of pitch, roll, and residual error of cervical vertebrae during body positioning.
分析螺旋断层放疗(HT)治疗鼻咽癌(NPC)时旋转和残余摆位误差与剂量偏差之间的关系。
2017 年 7 月 25 日至 2019 年 8 月 20 日,纳入 16 例接受治疗的 NPC 患者,对其进行全靶区兆伏 CT(MVCT)每隔一天扫描。使用自适应放疗功能应用软件 MIM7.1.3 累积实际剂量。比较患者靶区和危及器官(OAR)初始计划剂量的剂量偏差,并分析剂量变化与摆位误差(旋转摆位误差和颈部残余摆位误差)之间的相关性。
平移摆位误差随远离头部的距离增加而增大。方差分析显示,左右方向( < .001)和前后方向( < .001)3 组间差异有统计学意义。与初始计划剂量相比,靶区实际累积剂量随 OAR 实际照射剂量增加而减少。然而,大多数剂量学参数差异小于 5%。未发现剂量偏差值与靶区平移摆位误差之间存在相关性。然而,矢状面旋转摆位误差(倾斜角)与 PTVnd(L)( = 0.885)、PTVnd(R)( = 0.547)、PTV1( = 0.633)和 PTV2( = 0.584)的平均剂量呈正相关( < .05)。横断面旋转摆位误差(滚转)与 PTVnd(R)( = 0.593)、PTV1( = 0.505)和 PTV2( = 0.662)的平均剂量呈正相关( < .05)。
实际累积剂量与初始计划剂量之间的剂量偏差不可忽视,但大多数指标差异小于 5%,接受 HT 治疗的 NPC 患者,每隔一天进行 MVCT 校正摆位误差,除非肿瘤迅速缩小或体重减轻,否则不需要进行自适应放疗模型。此外,为了最大限度地减少剂量偏差,在定位时应更加注意减少倾斜角、滚转和颈椎残余误差。